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Background: Tangle-predominant dementia (TPD) is characterized neuropathologically by numerous neurofibrillary
tangles in the limbic areas with no or occasional senile plaques throughout the brain. TPD is an under-recognized
disease, while it is a common cause of dementia in those over 80 years of age. In the present study, we describe
hyperphosphorylated tau (tau) accumulation in the nucleus accumbens (Acb) in patients with TPD.
Results: We investigated immunohistochemically the brain tissues from 7 patients with TPD, 22 with Alzheimer
disease (AD) and 11 non-demented aged subjects. In the Acb of all 7 TPD patients, a considerable number of tau
positive neurons were found together with many neuropil threads. The tau deposits in the Acb were labeled with
all the anti-tau antibodies used in the present study. They included conformational change-specific,
phosphorylation-specific and phosphorylation-independent antibodies. The Acb consists of the predominant
medium-sized neurons with a small number of large neurons. Both the cell types were affected by tau pathology in
TPD. Tau accumulation in the majority of such neurons appeared to be pretangle-like, diffuse deposits with only
occasional paired helical filament formation. Tau positive neurons were also found in the Acb in some AD and
non-demented aged subjects but much fewer in the majority of cases. The immunoblot analyses of fresh frozen
samples of the Acb and parahippocampal cortex from 3 TPD and 3 AD patients revealed that the insoluble tau in
the Acb was a mixture of the 3- and 4-repeat isoforms.
Conclusions: To our knowledge, this is the first report on the occurrence of tau accumulation in the Acb in TPD.
The Acb receives direct and massive projections from the hippocampal CA1 and subiculum where neurofibrillary
tangles are known to occur more frequently in TPD than in AD. The prevalence of abnormal tau accumulation in
the Acb in TPD may support the idea that abnormal tau aggregation propagates via neural circuits. In all but one
TPD cases used in this study, delusion was a consistent clinical feature. Whether the Acb tau accumulation is related
to the psychiatric symptoms in TPD may be an issue for further investigation.
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Tangle-predominant dementia (TPD), which is also re-
ferred to as neurofibrillary tangle predominant dementia,
limbic neurofibrillary tangle dementia or senile dementia
of the neurofibrillary tangle type, is a poorly understood
and under-recognized tauopathy. TPD has been reported
to comprise 0.7 to 5.8% of elderly patients with dementia
[1-3]. TPD is characterized neuropathologically by numer-
ous neurofibrillary tangles (NFT) in the limbic areas with* Correspondence: akiyama-hr@igakuken.or.jp
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unless otherwise stated.no or occasional senile plaques throughout the brain. The
clinical features of TPD include the late-adult onset, which
is over 80 years in the majority of cases, and slow progres-
sion of dementia as compared with Alzheimer’s disease
(AD). In patients with TPD, there is a propensity for the
memory disturbance to be conspicuous with relative pres-
ervation of other cognitive functions. However, it is hard
to distinguish TPD from AD on a clinical basis and, thus,
diagnosis of TPD in most cases is only made postmortem.
The etiology of TPD is unknown. NFT in TPD consist
of both 3-repeat (3R) and 4-repeat (4R) isoforms of hyper-
phosphorylated tau (tau), and the neuronal cell typesral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 A semi-macro photograph of the basal ganglia from a
TPD case stained with AT8. Faint immunoreaction is seen in the
nucleus accumbens (Acb), lateral septal nucleus (LS) and the
olfactory tubercle (Tu) even at this low power magnification.
Ca: caudate nucleus; Put: putamen. Scale bar = 1 cm.
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seems to be a disorder that is related to AD, if it is not an
atypical form of AD. TPD, as a subtype of tauopathy, is also
included in the group described as neuropathologically-
defined frontotemporal lobar degeneration [4,5]. In fact,
cortical lesions in TPD are localized to the mediobasal
temporal cortex. Thus, the situation of TPD in the groups
of dementing neurodegenerative diseases remains unclear
from both clinical and neuropathological points of view.
A neuropathological characteristic of TPD is the heavy
accumulation of NFT in the hippocampal regions, with
few or occasional NFT in neocortical areas beyond the
collateral sulcus. Compared with AD patients in which a
similar number of NFT occurs in the hippocampal re-
gions, neuronal cell loss, tissue rarefaction and gliosis
are less prominent in TPD, even in NFT rich areas.
Changes in the neocortex are modest, with well-
preserved laminar structures and unremarkable neuronal
cell loss. The cortical expansion of NFT in TPD is con-
sidered to follow in principle the hierarchical pathway
described in AD by Braak and Braak [6] but to be lim-
ited to stage IV. In the hippocampal regions, the density
of NFT is higher than in AD [7] and ghost tangles are
very frequent [3]. Tau pathology in the subcortical struc-
tures in TPD has not been well studied. The occurrence
of NFT in the amygdala, the nucleus basalis of Meynert,
the substantia nigra and the locus coeruleus, regions
where NFT frequently occur in AD cases, have been
reported in TPD [3,8].
The nucleus accumbens (Acb) is located in the region
where the caudate head and the rostral putamen meet
near the septum pellucidum (Figure 1). The Acb and
the olfactory tubercle form the ventral striatum in the
forebrain. The Acb is a key component of the limbic
striatal loop in which the Acb receives fibers from the
prefrontal cortex, amygdala, hippocampus and ventral
tegmental area (VTA) and projects to the ventral palli-
dum [9-12]. The ventral pallidum sends axonal projec-
tions to the dorsomedial thalamic nucleus, which then
projects to the prefrontal cortex to close the loop [13,14].
The dopaminergic input from the VTA modulate the
activity of this loop [15]. The Acb is considered to be
involved in cognition, emotion and emotional behaviors
such as pleasure, fear, aggression, addiction and reward
[16,17]. The limbic striatal loop is, therefore, one of the
major targets of studies on the pharmacological actions of
anti-psychotic drugs [18,19].
In the present study, we found the frequent and consist-
ent tau accumulation in the Acb in TPD. Tau positive
neurons were also found in the Acb in some AD and on-
demented aged subjects but much fewer in the majority of
such cases. We speculate that the lesions in the Acb play a
role in some psychiatric symptoms such as delusion,
which is often conspicuous in TPD.Materials and methods
We used brain tissues, archived in our laboratory, from 7
patients with TPD, 22 with AD and 11 subjects without
dementia or other neurological disease. The demography,
Braak and Braak’s NFT stages and brain weight in each
patient group are summarized in Table 1. Diagnoses were
initially made on a clinical basis and were confirmed in
every case by neuropathological examination. Clinical and
neuropathological diagnoses of TPD followed the descrip-
tions in previous articles [3,7,20]. Diagnoses of AD were
made if the CERAD plaque score was ‘C’ [21] and the
Braak and Braak’s NFT stage was IV or higher [6]. In TPD
and AD cases with the NFT stage III or IV, Lewy body
pathology was confirmed to be absent or mild/stage 1 [22]
in the hippocampus, parahippocampal gyrus and temporal
neocortex to exclude the possibility of Dementia with
Lewy bodies. In all cases, the patient or, in any case where
the patient had died, his/her next of kin gave the written
consent for autopsy and postmortem analyses for research
purposes. This study was approved by the ethics commit-
tee in the Tokyo Metropolitan Institute of Medical Science
and was performed in accordance with the ethical stan-
dards laid down in the 1964 declaration of Helsinki and its
later amendments.
Table 1 Summary of patient groups used in this study
TPD AD Non-demented
Braaks’ NFT stages III or IV IV V VI I-III
Number of cases 7 10 8 4 11
Gender (male/female) 1/6 6/4 4/4 2/2 7/4
Age at death* 88.4 ± 7.2 81.5 ± 8.5 86 ± 3.5 81.5 ± 8.8 81 ± 7.0
Disease duration (y)* 4.7 ± 2.9 6.1 ± 6.7 6.2 ± 3.5 6.6 ± 6.0 n/a
Brain weight (g)* 1,137 ± 135.3 1,134 ± 174.8 1,119 ± 77.2 1,008 ± 156.5 1,146 ± 77.1
TPD, Tangle-predominant dementia; AD, Alzheimer’s disease; NFT, neurofibrillary tangles.
*Data are shown as mean ± S.D.
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fixed, paraffin-embedded brain blocks were cut into
10 μm thick sections and stained with hematoxylin and
eosin (HE), Klüver-Barrera, modified Gallyas-Braak and
methenamine silver staining. Tissue sections of the med-
iobasal temporal cortex containing the hippocampus, en-
torhinal cortex and temporal neocortex were stained for
tau and amyloid β protein (Aβ) by immunohistochemis-
try. Sections of the rostral striatum with the Acb and the
septal nuclei were stained for tau. In TPD cases, add-
itional tau immunohistochemistry was performed for the
nucleus basalis of Meynert, amygdala and substantia
nigra. The hippocampus, parahippocampal gyrus and ad-
jacent temporal neocortex were also stained for phos-
phorylated α-synuclein and phosphorylated TDP-43 in
TPD cases.
For more detailed immunohistochemical analyses, small
blocks of brain the tissues were dissected at autopsy and
fixed in 4% paraformaldehyde (PFA) for 2 days. The cryo-
cut sections of 30 μm thickness were used for the high
sensitive, free-floating immunhistochemical staining [23].
The antibodies used in this study are listed in Additional
file 1: Table S1. The primary antibody labeling was visual-
ized with 3,3′-diaminobenzidine as a chromogen, in com-
bination with the Envision Plus® kit (Dako Japan, Tokyo).
For enhanced thioflavin-S staining, tissue sections were
pretreated with KMnO4 for 20 min and, subsequently,
with sodium borohydride for 4 min [24]. Sections were
then stained with 0.05% thioflavin-S in 50% ethanol in the
dark for 8 min, followed by differentiation in two changes
of 80% ethanol for 10 sec each time and three washes in
large volumes of distilled water. Following incubation in a
high salt solution containing 411 mM NaCl, 8.1 mM KCl,
30 mM Na2HPO4 and 5.2 mM KH2PO4, pH 7.2 at 4°C for
30 min, sections were briefly rinsed with distilled water
and observed by fluorescence microscopy.
For immunoelectron microscopy, both post-embedded
and pre-embedded procedures were used. For the former,
the 4% PFA-fixed small tissues were embedded in LR
White Resin® (London Resin, U.K.) without further fix-
ation. The ultra-thin sections were stained with AT8,
which was followed by incubation with anti-mouse IgGconjugated with 10 or 20 nm gold colloidal particles
(BBinternational, U.K.). For the pre-embedding procedure,
the 4% PFA-fixed free-floating sections were stained with
AT8 in combination with Alexa Fluor 488 FluoroNano-
gold anti-mouse IgG (Nanoprobes, U.S.A.). Following
examination by fluorescence microscopy to localize the
positive labeling, the sections were postfixed with 2% glu-
taraldehyde and then treated with HQ Silver Enhancement
Kit (Nanoprobes, U.S.A.). After the treatment with 1% os-
mium tetroxide, which was followed by 2% uranyl acetate,
the sections were embedded in epoxy resin (Querol 812,
Nissin EM, Japan). Ultrathin sections were cut and ob-
served by a transmission electron microscope (JEM-1400,
JEOL, Japan).
For immunoblot analyses, fresh frozen samples of the
Acb and the parahippocampal cortex were obtained from 3
TPD cases (cases 3, 4 and 6) and 3 AD cases. The Braak
and Braak’s NFT stages of the AD cases were 4, 5 and 6,
respectively. Brain tissue was homogenized in 2 vol of TS
buffer (50 mM Tris–HCl, 150 mM NaCl, pH 7.5), with a
mixture of protease inhibitors and centrifuged at 200,000 g
for 20 minutes at 4°C. The supernatant was taken as the
soluble fraction and the pellet was used to further extract
the sarkosyl-insoluble fraction as described previously [25].
Dephosphorylation of the sarkosyl-insoluble fractions was
performed by incubation of the samples with Escherichia
coli alkaline phosphatase (type III, Sigma) as described
previously [25]. HT7, a pan-tau monoclonal antibody
(Additional file 1: Table S1), was used for immunoblotting.
Primary antibody labeling on the membranes was visual-
ized with 3,3′-diaminobenzidine as a chromogen, in com-
bination with a Vectastain ABC kit® (Vector Lab., USA).
For semiquantitative analyses of immunohistochemically
stained tissue sections, the density of AT8 positive tau ac-
cumulation was graded to be 0 for absent, 1 for low, 2 for
intermediate and 3 for high, based on microscopic obser-
vations at ×200 magnification. The Acb, septal nuclei,
caudate nucleus, hippocampal CA1, entorhinal cortex and
temporal neocortex were assessed in TPD, AD and non-
demented aged subjects. The Mann–Whitney U test was
used for statistical analyses using Graph Pad Prism 4
software (Graph Pad Software, U.S.A.).
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TPD cases used in the present study
The demographic, pathologic, and clinical information
of the TPD cases used in the present study is summa-
rized in Tables 1 and 2. In general, both the clinical and
neuropathological features are similar to those de-
scribed in previous reports [1-3,7,26,27]. The average
age at death is higher than that in AD. Moderate de-
mentia was noted in 5 of the 7 cases but the other two
were diagnosed as having mild cognitive impairment.
Delusion was evident in 6 cases. Brain atrophy was mild,
if present, and senile plaques were either absent or rare.
Lacunar infarcts were seen in the globus pallidus in 2
cases. In all cases, heavy tau accumulation was seen in
the limbic regions in the forms of NFT, diffuse cytoplas-
mic accumulations and neuropil threads. Tau accumula-
tion was heavier in the subiculum and the CA1 region
than in the entorhinal and transentorhinal cortices. Tau
was also deposited in the amygdala, the septal nuclei
and the basal nucleus of Meynert, and, less frequently, in
the caudate nucleus and substantia nigra. A small
amount of tau was found in the temporal neocortex but
only in 3 cases. Such limbic-predominant distribution
of tau pathology is consistent with previous reports
[1,2,26,28]. A small number of argyrophilic grains were
present in 2 cases.Table 2 Demography and basic clinical and neuropathologica
Case 1 Case 2 Cas
Age at death 89 102 9
Sex F F F
Dementia + + +
Psychiatric symptoms
Delusion + + +
Anxiety + - -
Depression - - -
Brain weight (g) 940 970 11
Atrophy mi(Fr) mi(Fr/T) -
Plaque stage (1) 0 0 A
NFT stage (1) III III II
Argyrophilic grain stage (2) 0 0 0
Hippocampal sclerosis - - +
Vascular lesions + - -
α-synuclein (hip/T**) +§ - -
TDP-43 (hip/T**) - - -
Acb tau score 3 2 2
F, Female; M, Male; MCI, Mild cognitive impairment; mi, Mild; Fr, Frontal; T, Tempora
seen in the temporal cortex. The Acb tau score was determined according to the m
on the description by Braak and Braak [6]. (2) The argyrophilic grain staging was ba
α-synuclein and TDP-43 was performed in tissue sections of the hippocampus, para
in this case was mild, corresponding to stage 1 by the 3rd report of the DLB consorTau accumulation in the Acb in TPD
In addition to the previously reported tau distribution,
we found a considerable number of tau positive neurons
in the Acb in all TPD cases used in this study (Figures 1
and 2). Similarly to the hippocampus, numerous neuro-
pil threads were associated with tau positive neurons
(Figure 2A). The tau positive neurons and neuropil
threads were labeled with all the anti-tau antibodies used
in the present study (Figures 2A-D). They included con-
formational change-specific, phosphorylation-specific and
phosphorylation-independent antibodies (Additional file 1:
Table S1). The staining pattern varied, which partly de-
pends on the affinity of the antibody and the localization
of the antigen epitope recognized by each antibody. Pres-
ervation of the epitope in tissue sections is affected by ag-
gregation, degradation and post-mortem processing such
as fixation. The majority of tau positive neurons in the
Acb showed pretangle-like, diffuse or granular accumula-
tion of tau in the cytoplasm (Figures 2B). Flame-like NFT,
the common form in the hippocampus in TPD, were also
present but not frequent (Figure 2B, arrow). The vast ma-
jority of tau positive neurons were medium sized but, occa-
sionally, large neurons were also stained positively for tau
(Figure 2D, arrow). Tau positive neurons and threads were
not distributed evenly in the Acb. Rather, areas with sparse-
and dense-tau pathology were intermingled (Figure 2E).l features of TPD cases
e 3 Case 4 Case 5 Case 6 Case 7
0 85 89 78 86
F F M F
+ MCI MCI +
+ + + -
- - - -
+ - - -
70 1300 1230 1220 1130
- - - -
* 0 0 0 0
I III IV III III
0 II II 0
- - - -
+ - - -
- - - -
- - - -
3 3 2 3
l; Acb, The nucleus accumbens. *A small number of diffuse Aβ deposits were
ethod described in the text. (1) The senile plaque and NFT staging were based
sed on the description by Saito et al. [29]. **Immunohistochemistry for
hippocampal gyrus and adjacent temporal neocortex. § α-Synuclein pathology
tium [22].
Figure 2 Tau accumulation in the Acb in TPD. A through G are immunohistochemistry with phosphorylation or conformational change
specific tau antibodies. A, B, C and I: 4% paraformaldehyde-fixed, frozen-cut, 30 μm thick Sections. D through H are formalin-fixed, 10 μm thick,
paraffin Sections. A: immunohistochemistry with AP422. Tau positive neurons are associated with many neuropil threads. Scale bars = 200 μm.
B: immunohistochemistry with PHF-1. The majority of tau positive neurons show pretangle-like, diffuse or granular cytoplasmic labeling. Among
them, apparent NFT are also seen but less frequently (arrow). Scale bar = 100 μm. C: immunohistochemistry with MC1, a conformational change
specific antibody. Scale bar = 100 μm. D through G are immunohistochemistry with AT8. D: the vast majority of tau positive neurons are of
medium-size but, occasionally, large neurons are also stained positively for tau (arrow). At the same magnification as C. E: tau positive neurons
are not evenly distributed in the Acb. Scale bar = 500 μm. F: a glial coiled body. Scale bar = 25 μm. G and H: the nearby sections from the same
case with AT8 immunohistochemistry (G) and Gallyas-Braak staining (H). I: thioflavin S staining reveals granular cytoplasmic labeling of neurons.
Scale bar = 100 μm.
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not all, of the cases (Figure 2F). Occurrence of glial coiled
bodies in other brain regions in TPD has been reported
previously [3]. Gallyas-Braak staining labeled only a small
number of NFT in the Acb, while tau immunohistochemis-
try of nearby sections from the same patient revealed many
positive cells (Figure 2G and 2H). Enhanced thioflavin-S
staining labeled many neurons (Figure 2I).
The density of tau positive neurons and neuropil threads
varied somewhat among the TPD cases. In TPD, no clear
association was seen between the degree of Acb tau path-
ology and the Braak and Braak’s NFT stage or the presence
or absence of Aβ deposits, argyrophilic grains [29] and
vascular lesions (Table 2). Despite the consistent tau accu-
mulation in the Acb in TPD, we were not able to find
severe neuronal loss or gliosis by HE staining.Immunoelectron microscopy of the Acb in TPD with a
tau antibody, AT8, revealed positive labeling of granular
structures in the neurons (Figure 3A). Small and sparse
bundles of short filamentous structures were occasionally
seen to be stained positively for AT8 in the neuronal
cytoplasm and neuropil (Figure 3B). Some of them showed
morphology consistent with paired helical filaments (PHF).
Thus, the ultrastructure of tau accumulation in the Acb
was different from that in the hippocampal CA1 region,
where dense and long bundles of PHF were frequent and
intensely labeled for AT8 (Figure 3C).
Tau pathology in the Acb in AD and non-demented
aged subjects
We then investigated the Acb in AD and non-demented,
aged subjects. Tau positive neurons were found in some,
Figure 3 Immunoelectron microscopy of TPD brain with AT8 and immunogold labeling. A: in the Acb, the immunogold labeling in
neurons was mostly localized to the granular structures (indicated by circles). Paired-helical filaments (PHF) were rare. Scale bar = 1.0 μm. B: sparse
bundles of PHF were scattered in the neuronal cytoplasm. Scale bar = 200 nm. C: in the hippocampal CA1 region, prominent bundles of AT8
positive PHF were seen. Scale bar = 500 nm.
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(Additional file 2: Figure S1A). In these groups, however,
only a limited number of cases showed tau pathology
which was similarly abundant to that in TPD (Figure 4). In
AD patients with heavy tau accumulation in the Acb, the
caudate nucleus was also affected, a feature which distin-
guished AD from TPD. In TPD, the caudate tau lesions
were either absent or, if present, very mild in all cases. In
addition, senile plaques with tau positive dystrophic neur-
ites were scattered in the Acb of such AD cases (Additional
file 2: Figure S1B). In AD cases with mild tau pathology in
the Acb, large neurons preferentially contained tau, a find-
ing which was similar to the caudate nucleus in AD. In AD
cases with heavy tau pathology in the Acb, such large
neuron predominance became unclear and many tauFigure 4 A graph of the density of neuronal tau accumulation
in the Acb. The density of tau accumulation was graded as being 0
for absent, 1 for low, 2 for intermediate and 3 for high. Statistically
significant differences were seen between TPD cases and
non-demented, aged subjects (P = 0.0031) as well as AD cases in
NFT stage IV (P = 0.0192) and V (P = 0.0022). The points encircled by
a broken line in the non-demented, aged group indicate that the
cases were over age 90.positive, medium-sized neurons were seen. In both AD
and non-demented, aged subjects, neuropil threads were
also present in those with tau positive neurons in the Acb
(Additional file 2: Figure S1C). The form of tau accumula-
tion in AD patients and non-demented, aged subjects was
similar to that in TPD, being predominantly pre-tangle
like, diffuse accumulation in the cytoplasm.
The density of neuronal tau accumulation was graded to
be 0 (absent) through 3(high) in AT8 immunostained tissue
sections. Figure 4 illustrates the results in the Acb. Tau
density in the Acb in the AD group was highly variable, ex-
cept that the cases in Braak and Braak’s NFT stage VI were
either grade 2 or 3. Statistically significant differences were
seen between the TPD cases and the non-demented, aged
subjects (P = 0.0031) as well as the AD cases with NFT
stage IV (P = 0.0192) and those with NFT stage V (P =
0.0022). Two non-demented, aged subjects with tau accu-
mulation in the Acb were both over age 90. These 2 cases,
similarly to TPD, lacked tau accumulation in the caudate
nucleus and showed more NFT in the subiculum than in
the entorhinal cortex. The results of semiquantitative ana-
lyses confirmed our observation that tau accumulation in
the Acb was a remarkable finding in TPD. We performed
similar analyses for a number of brain regions. The results
are summarized in Table 3 as the averages of the graded
scores for tau accumulation in each group. The concentra-
tion of tau pathology in the limbic structures, including the
Acb and septal nuclei, in TPD contrasted with the broad
distribution over the neocortex in AD.
Immunoblot analyses
The results of immunoblot analyses of samples from TPD
and AD patients are shown in Figure 5. The tau band pat-
terns in the sarkosyl insoluble fraction appeared to be es-
sentially the same between TPD and AD, while the amount
of insoluble tau was far smaller in the Acb than in the para-
hippocampal cortex in AD. It has to be noted that, because
of the very high concentrations of insoluble tau in the para-
hippocampal cortex samples, the amounts of samples
Table 3 Summary of the semiquantitative grading of tau accumulation
Braak stage No. of cases Acb Caudate nucleus Septal nucleus CA1 Ent Temp
TPD III-IV 7 2.6 0.7 2.2 3 2.57 0.4
Non-demented I-II 3 0 0 0 0.67 1 0
III 8 1.13 0.25 0.63 1.38 2 1
AD IV 10 1.2 0.6 1.4 2.67 3 1.4
V 8 0.9 0.9 1.3 2.89 2.9 2.5
VI 4 1.3 1.3 1.7 3 3 3
The numbers indicate averages of the scores in each group. The degree of tau pathology was qualitatively scored as 0: absent 1: low 2: intermediate 3: high.
TPD, Tangle predominant dementia; AD, Alzheimer’s disease; NFT, Neurofibrillary tangles; Acb, nucl. Accumbens; CA1, Hippocampal CA1 region; Ent, Entorhinal
cortex; Tmep, Temporal neocortex.
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resulted in the relatively weak signals for the Acb samples
in AD cases. The dephosphorylated samples of the Acb and
parahippocampal cortex showed the 3R + 4R isoform pat-
tern in both TPD and AD.The Acb tau pathology and the presence/absence of
clinical history of delusion
Finally, we examined if the degree of the Acb tau path-
ology was different between the subjects groups with
and without the history of delusion in the clinical re-
cords (Additional file 3: Figure S2). In the group of sub-
jects with Braaks’ NFT stages III and IV, which included
NFT stage III non-demented aged subjects, all TPD
cases and NFT stage IV AD cases, the Acb tau score was
higher in those with clinical history of delusion than those
without it (p = 0.033). Similarly, the less conspicuous butFigure 5 Immunoblot analyses of the sarkosyl insoluble tau. The sarko
(T) from TPD (A) and AD (B) were analyzed by immunoblot. A pan-tau ant
pattern similar to that in the parahippocampal cortices in both TPD and ADstill significant difference was seen in the group of all NFT
stage AD cases (p = 0.049).
Discussions
There is significant overlap in the distribution of NFT
between TPD and AD. However, an early genetic study of
TPD cases indicated a paucity of the apolipoprotein E ε4
allele, which currently is the most powerful risk factor for
AD [30]. More recently, a report has been made on the
significant associations of TPD with the MAPT H1 haplo-
type as well as with some polymorphisms within the re-
gion of MAPT encoding the 3′ UTR [31]. Thus, together
with the striking paucity of Aβ deposition, it seems that
TPD is a unique neuropathological entity that has to be
studied separately from AD.
The clinical and neuropathological features of the TPD
patients we used in the present study generally agreed
with those described in preceding articles [3,32]. Insyl insoluble fractions of the Acb (A) and the parahippocampal cortex
ibody, HT7, was used. The Acb samples show the 3R + 4R isoform
.
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pathology, we found a considerable number of tau posi-
tive neurons and neuropil threads in the Acb. The Acb
consists of the predominant medium-sized neurons and
the occasional large neurons. Both cell types were af-
fected by tau pathology in TPD. This contrasted AD
with mild Acb tau pathology, in which large neurons
were affected preferentially. Such a result is consistent
with the previous reports which described that large
neurons are more vulnerable in AD [33] and prone to
tau accumulation [34]. In AD cases with the heavy Acb
tau pathology, many medium-sized neurons were also
tau positive. In the absence of TPD cases with the mild
Acb tau pathology, it remains to be determined whether
the difference is attributable to the distinct pathome-
chanisms between AD and TPD or to the variable
vulnerability of different neuronal cell types.
The Acb may not be a region which is routinely sam-
pled in a number of laboratories. Further, tau pathology
in the Acb is not well stained by the Gallyas-Braak
method. These facts together might explain the absence
of previous reports on the occurrence of tau lesions in
the Acb. The mechanism by which the Gallyas-Braak
staining labels NFT remains to be determined. In TPD,
insoluble tau consists of a mixture of the 3R and 4R iso-
forms in both the Acb and hippocampus, but NFT are
intensely labeled by Gallyas-Braak staining in the latter.
It may be noteworthy that, in the Acb, tau pathology
occurs in a form of diffuse or granular cytoplasmic accu-
mulations in the majority of tau positive neurons and
that, ultrastructurally, PHF were rare. These contrasted
with the hippocampal lesions where dense bundles of
PHF were frequently seen. Obviously, factors that affect
the reactivity of abnormal tau deposits to Gallyas-Braak
staining need further clarification.
Tau pathology is considered to propagate in the brain
from an affected region to another along the fiber connec-
tions, by spreading through the neuropil, or by both. A
proposed mechanism for such propagation is a prion-like,
seed-dependent conformational change and subsequent
aggregation of the molecule, with a breakdown of the
aggregate that generates the next seeds. In such a manner,
the tau isoform pattern in the initial aggregates may be
maintained in the later aggregate formations [35]. In the
present study, we found that the Acb lesion in TPD was
3R + 4R tauopathy, a result which suggests the common
origin of the tau pathology in the Acb with that in the
hippocampus. The prevalence of diffuse cytoplasmic accu-
mulations suggests that tau pathology in the Acb occurs
later in the disease progression. In the hippocampus in
TPD, many ghost tangles are seen, suggesting that the
hippocampal lesions precede the Acb lesions.
Occurrence of NFT in the Acb in AD was reported
previously [36,37]. In the present study, however, we havefound that tau accumulation in TPD is more frequent and
consistent than AD. The Acb receives direct and massive
projections from the hippocampal CA1 and subiculum
[14,38,39]. It has been repeatedly reported in TPD that the
density of NFT is higher in the hippocampal CA1 and
subiculum than in the entorhinal cortex [1,2,7,28]. Thus,
the heavy tau pathology in the subiculum and CA1,
through neural circuit-mediated propagation to the Acb,
may result in the more pronounced tau accumulation in
the Acb in TPD than in AD. Such an idea may be consist-
ent with our finding that the difference in Acb tau path-
ology was statistically significant between TPD and AD in
NFT stages IV and V but not in AD at stage VI. In AD
with Acb lesions, tau accumulation was also found more
frequently in the caudate nucleus than was the case in
TPD. The caudate nucleus receives massive innervations
from the cerebral cortex where, unlike TPD, tau pathology
is severe in AD. On the other hand, the septal nuclei, like
the Acb, receive direct projections from the subiculum
and CA1 [14,38]. Again, we found, in the present study,
heavier tau accumulation in these areas in TPD than in
AD at NFT stages IV and V.
TPD is primarily an amnestic disease with relatively
mild non-amnestic symptoms of dementia. In 6 of 7 TPD
cases used in this study, however, delusion was a consist-
ent clinical feature. This may be partly attributable to the
fact that our brain tissue archive is principally based on
the psychiatric hospital autopsies. However, occurrence of
psychiatric symptoms has also been described in a number
of previous reports on TPD. As an example, Jellinger et al.
reported depression in 17.5% and paranoid ideas in 15% of
TPD cases [3]. The Acb is part of the mesolimbic system
in which the Acb receives dopaminergic input from the
VTA. Recent evidence suggests that, in schizophrenia,
functional abnormality in the Acb causes excessive release
of dopamine from the VTA, which then results in the
psychiatric symptoms [19,40-43]. While neuronal loss was
not apparent in the Acb in TPD, it may be noteworthy
that association of intraneuronal tau aggregation with
clinical symptoms has been suggested in early stage AD
lesions [44]. In AD, cases with more neocortical NFT were
reported to be associated with more psychosis [45]. Thus,
tau accumulation in the Acb could be related to the
frequent delusion in TPD. Delusion and other psychotic
symptoms may occur by multiple mechanisms in demen-
tia patients. We have to note that 2 of the 7 TPD cases
had argyrophilic grain pathology and that psychotic
symptoms are known to be common in the patients with
argyrophilic grain disease [46]. Whether the Acb tau
accumulation is related to the psychiatric symptoms in
TPD may be an issue for further investigation.
In the present study, we found that tau pathology
occurred unevenly in the Acb in TPD (Figures 1 and 2E).
The striatum is not uniform and has distinct neurochemical
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and striosomes. The similar but more complex compart-
mentation was reported in the human Acb [47]. We have
performed additional immunohistochemistry for tyrosine
hydroxylase (TH) and tau in serially-cut, free-floating
sections in two TPD cases, in which the remnants of Acb
blocks were available after the initial sectioning for the
main body of this study. Comparison of the adjacent
sections stained for TH and tau indicates that tau pathology
preferentially occurs in areas where the fine, mesh-like TH
staining is relatively light (Additional file 4: Figure S3). Such
a result suggests the relationship between the uneven distri-
bution of tau pathology and neurochemical heterogeneity
in the Acb. However, because of the limited number of
currently available samples and of the more complex neuro-
chemical architecture in the Acb than the simple matrix-
striosome structure in the caudate nucleus [47], future,
extensive studies should be needed for further exploration.
Conclusions
We have found frequent tau accumulation in the Acb in
patients with TPD. Both the medium-sized and large
neurons are affected. While similar tau accumulation was
seen in a small number of all AD patients, it was far more
frequent and consistent in TPD than AD. The tau isoforms
abnormally accumulated in the Acb were 3R and 4R, which
suggests a common origin with the hippocampal tau path-
ology. The Acb receives direct and massive projections
from the hippocampal CA1 and subiculum where tau path-
ology is extremely severe in TPD. Such a result may sup-
port the idea that abnormal tau aggregation propagates via
neural circuits. Tau accumulation in TPD should be a sub-
ject of further investigations to approach the long-lasting
issue of the simultaneous deposition of Aβ and tau in AD.
In addition, the relationship between the tau pathology in
the Acb and such psychiatric symptoms as delusion in TPD
needs further exploration.Additional files
Additional file 1: Table S1. The primary antibodies used in this study.
Additional file 2: Figure S1. Tau accumulation in the Acb in AD and
non-demented, aged subjects. Immunohistochemistry with AT8. A:
absence of tau positive neurons in an AD case in Braak and Braak’s NFT
stage IV. Scale bar = 100 μm in A-C. B: a diffuse cytoplasmic staining,
neuropil threads and duystrophic neurite in a senile plaque in an AD case
in NFT stage VI. C: a tau positive neuron and neuropil threads in a
non-demented, aged subject.
Additional file 3: Figure S2. A graph of the density of neuronal tau
accumulation in the Acb. The left plots: the group of Braaks’ NFT stages III
and IV, which includes non-demented aged subjects, TPD cases and AD
cases with Braaks’ NFT stage IV. Cases with delusion in the clinical history
show higher tau score than those without delusion in the Acb. The right
plots: the group of AD cases with Braaks’ NFT stages IV through VI. Again,
cases with delusion show higher tau score than those without delusion.Additional file 4: Figure S3. The serial section immunohistochemistry
for tau and tyrosine hydroxylase (TH). Forty micrometer thick, free
floating sections were cut serially from two tangle predominant
dementia (TPD) cases, in which the remnants of Acb blocks were
available after the initial sectioning for the main body of the study. A set
of every other section was stained for TH and the other set for tau with
AT8. A and C: AT8 staining in a TPD case 1. B: TH staining of the section
between A and C. In B, two types of areas are distinguished based on
the modest difference in the density of fine, mesh-like TH staining. There
is a propensity that tau pathology preferentially occurs in areas where the
fine, mesh-like TH staining is relatively light (A, C). Scale bar = 2 mm in A
(A, B and C are at the same magnification). D: higher power photomicro-
graphs of the boxed areas in B and C. The left half is the staining with AT8
and the right half staining for TH. Scale bar = 400 micro-m (D).
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